Anti-CS1 CAR-T Preclinical in vivo Assay

TypeName: Business Offer
Category:
Offer Date:2019/06/24
Country: United States
Summary: Creative Biolabs provides GLP-compliant in vivo test services for anti-CS1 CAR-T cell therapy in multiple myeloma. CS1 or SLAMF7, CD319 is a cell-surface glycoprotein, which is manifested as a robust marker in CD138-purified primary tumor cells from the majority of multiple myeloma (MM) patients.
Description: https://www.creative-biolabs.com/car-t/anti-cs1-car-t-preclinical-in-vivo-assay.htm
OfferId: 4665
Name:Creative Biolabs
Telphone:
Categories